236 research outputs found
Assessment of genetically modified maize Bt11\ua0x\ua0MIR162\ua0x\ua01507\ua0x\ua0GA21 and three subcombinations independently of their origin, for food and feed uses under Regulation (EC) No\ua01829/2003 (application EFSA-GMO-DE-2010-86)
In this opinion, the GMO Panel\ua0assessed the four-event stack maize Bt11\ua0
7\ua0MIR162\ua0
7\ua01507\ua0
7\ua0GA21 and three of its subcombinations, independently of their origin. The GMO Panel\ua0previously assessed the four single events and seven of their combinations and did not identify safety concerns. No new data on the single events or the seven subcombinations leading to modification of the original conclusions were identified. Based on the molecular, agronomic, phenotypic and compositional characteristics, the combination of the single events in the four-event stack maize did not give rise to food/feed safety issues.\ua0Based on the nutritional assessment of the compositional characteristics of maize Bt11\ua0
7\ua0MIR162\ua0
7\ua01507\ua0
7\ua0GA21, foods and feeds derived from the genetically modified (GM) maize are expected to have the same nutritional impact as those derived from non-GM maize varieties. In the case of\ua0accidental release of viable grains of maize Bt11\ua0
7\ua0MIR162\ua0
7\ua01507\ua0
7\ua0GA21 into the environment, this\ua0would not raise environmental safety concerns. The GMO Panel\ua0concludes that maize Bt11\ua0
7\ua0MIR162\ua0
7\ua01507\ua0
7\ua0GA21 is nutritionally equivalent to and as safe as its non-GM comparator in the context of the scope of this application. For the three subcombinations included in the scope, for which no experimental data were provided, the GMO Panel\ua0assessed the likelihood of interactions among the single events and concluded that their combinations would not raise safety concerns. These maize subcombinations are therefore expected to be as safe as the single events, the previously assessed subcombinations and the four-event stack maize. The post-market environmental monitoring plan and reporting intervals are in line with the intended uses of maize Bt11\ua0
7\ua0MIR162\ua0
7\ua01507\ua0
7\ua0GA21 and its subcombinations. A minority opinion expressed by a GMO Panel\ua0member is appended to this opinion
Assessment of genetically modified maize Bt11 Ă MIR162 Ă MIR604 Ă 1507 Ă 5307 Ă GA21 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSAâGMOâDEâ2011â103)
Maize Bt11 Ă MIR162 Ă MIR604 Ă 1507 Ă 5307 Ă GA21 (sixâevent stack maize) was produced by conventional crossing to combine six single events: Bt11, MIR162, MIR604, 1507, 5307 and GA21. The GMO Panel previously assessed the six single events and 22 of their combinations and did not identify safety concerns. No new data on the maize single events or their 22 combinations that could lead to modification of the original conclusions on their safety have been identified. The molecular characterisation, comparative analysis (agronomic, phenotypic and compositional characteristics) and the outcome of the toxicological, allergenicity and nutritional assessment indicate that the combination of the single maize events and of the newly expressed proteins in the sixâevent stack maize does not give rise to food and feed safety and nutritional concerns. The GMO Panel concludes that the sixâevent stack maize, as described in this application, is as safe as and nutritionally equivalent to its nonâGM comparator and the nonâGM reference varieties tested. In the case of accidental release of viable grains of the sixâevent stack maize into the environment, this would not raise environmental safety concerns. The GMO Panel assessed the likelihood of interactions among the single events in the 34 maize subcombinations not previously assessed and concludes that these are expected to be as safe as and nutritionally equivalent to the single events, the previously assessed subcombinations and the sixâevent stack maize. The postâmarket environmental monitoring plan and reporting intervals are in line with the intended uses of the sixâevent stack maize. Postâmarket monitoring of food/feed is not considered necessary. The GMO Panel concludes that the sixâevent stack maize and its subcombinations are as safe as its nonâGM comparator and the tested nonâGM reference varieties with respect to potential effects on human and animal health and the environment
Assessment of genetically modified maize MON89034x1507xNK603xDAS-40278-9 and subcombinations independently of their origin for food and feed uses, import and processing, under Regulation (EC) No1829-2003 (application EFSA-GMO-NL-2013-112)
Maize MON 89034 Ă 1507 Ă NK603 Ă DASâ40278â9 (fourâevent stack maize) was produced by conventional crossing to combine four single events: MON 89034, 1507, NK603 and DASâ40278â9. The GMO Panel previously assessed the four single events and four of their subcombinations and did not identify safety concerns. No new data on the maize single events or their four subcombinations that could lead to modification of the original conclusions on their safety have been identified. The molecular characterisation, comparative analysis (agronomic, phenotypic and compositional characteristics) and the outcome of the toxicological, allergenicity and nutritional assessment indicates that the combination of the single maize events and of the newly expressed proteins in the fourâevent stack maize does not give rise to food/feed safety and nutritional concerns. The GMO Panel concludes that the fourâevent stack maize, as described in this application, is as safe as and nutritionally equivalent to its nonâGM comparator and the nonâGM reference varieties tested. In the case of accidental release of viable grains of the fourâevent stack maize into the environment, this would not raise environmental safety concerns. The GMO Panel assessed the likelihood of interactions among the single events in the six maize subcombinations for which no experimental data were provided, and concludes that these are expected to be as safe as and nutritionally equivalent to the single events, the previously assessed subcombinations and the fourâevent stack maize. The postâmarket environmental monitoring plan and reporting intervals are in line with the intended uses of the fourâevent stack maize. No postâmarket monitoring for food/feed is necessary. The GMO Panel concludes that the fourâevent stack maize and its subcombinations are as safe as its nonâGM comparator and the tested nonâGM reference varieties with respect to potential effects on human and animal health and the environment
Assessment of genetically modified soybean MON 87708 Ă MON 89788 Ă A5547â127, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSAâGMOâNLâ2016â135)
Soybean MON 87708 Ă MON 89788 Ă A5547â127 (threeâevent stack soybean) was produced by conventional crossing to combine three single events: MON 87708, MON 89788 and A5547â127. The GMO Panel previously assessed the three single events and did not identify safety concerns. No new data on the single events, leading to modification of the original conclusions on their safety have been identified. The molecular characterisation, comparative analysis (agronomic, phenotypic and compositional characteristics) and the outcome of the toxicological, allergenicity and nutritional assessment indicate that the combination of the single soybean events and of the newly expressed proteins in the threeâevent stack soybean does not give rise to food and feed safety and nutritional concerns. The GMO Panel concludes that the threeâevent stack soybean, as described in this application, is as safe as and nutritionally equivalent to its conventional counterpart and the nonâGM reference varieties tested. The nutritional impact of food/feed derived from the threeâevent stack soybean is expected to be the same as that of food/feed derived from the conventional counterpart and nonâGM reference varieties. In the case of accidental release of viable seeds of the threeâevent stack soybean into the environment, this would not raise environmental safety concerns. The postâmarket environmental monitoring plan and reporting intervals are in line with the intended uses of the threeâevent stack soybean. Postâmarket monitoring of food/feed is not considered necessary. The GMO Panel concludes that the threeâevent stack soybean is as safe as its conventional counterpart and the tested nonâGM reference varieties with respect to potential effects on human and animal health and the environment
Assessment of genetically modified maize MON 87427 à MON 87460 Ă MON 89034 Ă MIR162 Ă NK603 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSAâGMOâNLâ2016â134)
Maize MON 87427 ĂMON 87460 Ă MON 89034 Ă MIR162 Ă NK603 (fiveâevent stack maize) was produced by conventional crossing to combine five single events: MON 87427, MON 87460, MON 89034, MIR162 and NK603. The GMO Panel previously assessed the five single maize events and eleven of the subcombinations and did not identify safety concerns. No new data on the single maize events or the 11 subcombinations that could lead to modification of the original conclusions on their safety were identified. The molecular characterisation, comparative analysis (agronomic, phenotypic and compositional characteristics) and the outcome of the toxicological, allergenicity and nutritional assessment indicate that the combination of the single maize events and of the newly expressed proteins in the fiveâevent stack maize does not give rise to food and feed safety and nutritional concerns. The GMO Panel concludes that the fiveâevent stack maize, as described in this application, is as safe as and nutritionally equivalent to its nonâGM comparator and the nonâGM reference varieties tested. In the case of accidental release of viable grains of the fiveâevent stack maize into the environment, this would not raise environmental safety concerns. The GMO Panel assessed the likelihood of interactions among the single events in the 14 maize subcombinations not previously assessed and concludes that these are expected to be as safe as and nutritionally equivalent to the single events, the previously assessed subcombinations and the fiveâevent stack maize. The postâmarket environmental monitoring plan and reporting intervals are in line with the intended uses of the fiveâevent stack maize. Postâmarket monitoring of food/feed is not considered necessary. The GMO Panel concludes that the fiveâevent stack maize and its subcombinations are as safe as its nonâGM comparator and the tested nonâGM reference varieties with respect to potential effects on human and animal health and the environment
EFSA guidance on the submission of applications for authorisation of genetically modified plants under Regulation (EC) No 1829/2003
This document provides guidance to applicants for submitting an application for authorisation of genetically modified (GM) plants for food and feed uses, import and processing, and/or cultivation in the European Union under Regulation (EC) No 1829/2003. The EFSA submission guidance describes the community procedures in the European Union for handling GM plant applications, and provides instructions to applicants on how to prepare and present data in an application. It is supplemented with seven appendices providing templates of data presentation to be followed by applicants, including a completeness checklist. The earlier versions are now updated to account for requirements outlined in Implementing Regulation (EU) No 503/2013. Instructions for submission described in this EFSA guidance are applicable to all GM plant applications submitted under Articles 5, 11, 17 and 23 of Regulation (EC) No 1829/2003
Statement on a conceptual framework for the risk assessment of certain food additives re-evaluated under Commission Regulation (EU) No 257/2010
The Panel on Food Additives and Nutrient Sources added to Food (ANS) provides a scientific statement presenting a conceptual framework for the risk assessment of certain food additives re-evaluated under Commission Regulation (EU) No 257/2010. This framework will be used in the evaluation made by the Panel, but the expert judgement of the scientific background, on a case-by-case basis, remains essential to reach a final conclusion. The outcome of the re-evaluation of food additives taking into account all available information is presented in the document, as well as the exposure assessment scenarios to be carried out by the Panel considering the use levels set in the legislation and the availability of adequate usage or analytical data
Recommended from our members
Guidance on safety evaluation of sources of nutrients and bioavailability of nutrient from the sources
Whenever new substances are proposed for use as sources of nutrients in food supplements, foods for the general population or foods for specific groups, EFSA is requested by the European Commission to perform an assessment of their safety and of the bioavailability of the nutrient from the proposed source. This guidance describes the scientific data required to allow an evaluation of the safety of the source within the established framework for risk assessment of food additives and novel food ingredients and the bioavailability of the nutrient from this source. This document is arranged in five main sections: one on technical data aimed at characterising the proposed source and at identifying potential hazards resulting from its manufacture and stability in food; one on existing authorisations and evaluation, providing an overview of previous assessments on the proposed source and their conclusions; one on proposed uses and exposure assessment section, allowing an estimate of the dietary exposure to the source and the nutrient based on the proposed uses and use levels; one on toxicological data, describing approaches which can be used to identify (in conjunction with data on manufacture and composition) and to characterise hazards of the source and any relevant breakdown products; the final section on bioavailability focuses on determining the extent to which the nutrient from the proposed source is available for use by the body in comparison with one or more forms of the same nutrient that are already permitted for use on the positive lists. This guidance document should replace the previous guidance issued by the Scientific Committee for Food and published in 2001
Assessment of genetically modified LLCotton25 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-010)
Following the submission of application EFSAâGMOâRXâ010 under Regulation (EC) No 1829/2003 from Bayer, the Panel on Genetically Modified Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application for the herbicideâtolerant genetically modified LLCotton25, for food and feed uses, import and processing, excluding cultivation within the EU. The data received in the context of this renewal application contained postâmarket environmental monitoring reports, a systematic search and evaluation of literature, updated bioinformatic analyses and additional documents or studies performed by or on behalf of the applicant. In addition, the applicant provided sequence data on the LLCotton25 event using the material from a commercial variety that, according to the applicant, may be imported into the EU at the time of this renewal application. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the context of the original application. The GMO Panel concludes that there is no evidence in the renewal application EFSAâGMOâRXâ010 for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on LLCotton25
- âŠ